Tag Archives: Tissue-Based Genomic Profiling Industry

Global Tissue-Based Genomic Profiling Industry, instrumental for cancer treatment advancements, will attain a valuation of US$ 2.2 billion by 2033, per FMI

In 2023, the global tissue-based genomic profiling industry is expected to be worth US$ 1.2 billion. The market is expected to reach US$ 2.2 billion by 2033, expanding at a 6.6% CAGR throughout the forecast period. In recent years, the market for tissue-based genetic profiling has grown significantly. The market is likely to grow further …

Continue reading “Global Tissue-Based Genomic Profiling Industry, instrumental for cancer treatment advancements, will attain a valuation of US$ 2.2 billion by 2033, per FMI”